Louisiana State Employees Retirement System - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 250 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
Louisiana State Employees Retirement System ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$892,206
-21.6%
19,400
-2.0%
0.02%
-20.0%
Q2 2023$1,137,906
+72.4%
19,800
+12.5%
0.02%
+47.1%
Q1 2023$660,000
+131374.1%
17,600
-1.7%
0.02%
+21.4%
Q4 2022$502
-99.9%
17,900
-2.2%
0.01%
-6.7%
Q3 2022$514,000
-22.9%
18,300
+0.5%
0.02%
-16.7%
Q2 2022$667,000
-4.7%
18,200
+1.7%
0.02%
+5.9%
Q1 2022$700,000
+68.7%
17,900
+0.6%
0.02%
+88.9%
Q4 2021$415,000
+22.8%
17,8000.0%0.01%
+12.5%
Q3 2021$338,000
+1.5%
17,800
+7.9%
0.01%0.0%
Q2 2021$333,000
+9.5%
16,500
-0.6%
0.01%0.0%
Q1 2021$304,000
-10.1%
16,600
-1.2%
0.01%
-20.0%
Q4 2020$338,000
+6.6%
16,800
-0.6%
0.01%
-33.3%
Q3 2020$317,000
+54.6%
16,900
+85.3%
0.02%
+25.0%
Q2 2020$205,000
-8.9%
9,120
-21.9%
0.01%
+9.1%
Q4 2019$225,000
-10.7%
11,680
-8.0%
0.01%
-15.4%
Q3 2019$252,000
-5.6%
12,700
-3.8%
0.01%0.0%
Q2 2019$267,000
+1.1%
13,200
+2.3%
0.01%0.0%
Q1 2019$264,000
+2.3%
12,900
-0.3%
0.01%
-13.3%
Q4 2018$258,000
-12.2%
12,941
-15.4%
0.02%
+15.4%
Q3 2018$294,000
+19.5%
15,300
-5.0%
0.01%
+18.2%
Q2 2018$246,000
-16.3%
16,100
+2.5%
0.01%
-15.4%
Q1 2018$294,000
+0.7%
15,700
+3.3%
0.01%0.0%
Q4 2017$292,000
+13.6%
15,200
+5.6%
0.01%
+8.3%
Q3 2017$257,000
-0.8%
14,400
-0.7%
0.01%
-7.7%
Q2 2017$259,000
+22.2%
14,500
-0.7%
0.01%
+18.2%
Q1 2017$212,000
-20.0%
14,600
+1.4%
0.01%
-21.4%
Q4 2016$265,000
-10.5%
14,400
-7.7%
0.01%
-12.5%
Q3 2016$296,00015,6000.02%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders